Skip to main content

4 articles related to "Cf Mice"

No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.

Articles

Original Research

Published on 27 Jul 2021

Assessment of Lentiviral Vector Mediated CFTR Correction in Mice Using an Improved Rapid in vivo Nasal Potential Difference Measurement Protocol

in Respiratory Pharmacology

P. Cmielewski
J. Delhove
M. Donnelley
D. Parsons

Frontiers in Pharmacology

doi 10.3389/fphar.2021.714452

3,480 views
5 citations

Original Research

Published on 20 May 2022

Treatment With LAU-7b Complements CFTR Modulator Therapy by Improving Lung Physiology and Normalizing Lipid Imbalance Associated With CF Lung Disease

in Inflammation Pharmacology

Amanda Centorame
Daciana Catalina Dumut
Mina Youssef
Martin Ondra
Irenej Kianicka
Juhi Shah
Radu Alexandru Paun
Tomas Ozdian
John W. Hanrahan
Ekaterina Gusev

Frontiers in Pharmacology

doi 10.3389/fphar.2022.876842

5,968 views
4 citations

Original Research

Published on 17 May 2022

Astragaloside IV Ameliorates Isoprenaline-Induced Cardiac Fibrosis in Mice via Modulating Gut Microbiota and Fecal Metabolites

in Microbiome in Health and Disease

Xu-Qin Du
Li-Peng Shi
Zhi-Wei Chen
Jin-Yuan Hu
Biao Zuo
Yu Xiong
Wen-Fu Cao

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2022.836150

7,245 views
42 citations

Original Research

Published on 12 Sep 2012

Decreasing Poly(ADP-Ribose) Polymerase Activity Restores ΔF508 CFTR Trafficking

in Pharmacology of Ion Channels and Channelopathies

Suzana Maria Anjos
Renaud Robert
Daniel Dirck Waller
Donglei Zhang
Haouaria Balghi
Heidi M. Sampson
Fabiana Ciciriello
Pierre Lesimple
Graeme Carlile
Julie Goepp

Frontiers in Pharmacology

doi 10.3389/fphar.2012.00165

7,051 views
15 citations